Common Contracts
3 similar Executive Employment Agreement contracts by Apogee Therapeutics, Inc.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 28th, 2023 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is entered into as of August 25, 2023 (the “Effective Date”), by and between Michael Henderson, MD (“Executive”) and Apogee Therapeutics, Inc. (the “Company”). This Agreement amends and restates in its entirety the Employment Agreement dated as of June 21, 2023.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 28th, 2023 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (the “Agreement”) is entered into as of August 25, 2023 (the “Effective Date”), by and between Carl Dambkowski (“Executive”) and Apogee Therapeutics, Inc. (the “Company”). This Agreement amends and restates in its entirety the Executive Employment Agreement dated as of August 28, 2022.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 28th, 2023 • Apogee Therapeutics, Inc. • Biological products, (no disgnostic substances) • Connecticut
This Executive Employment Agreement (the “Agreement”) is entered into as of August 25, 2023 (the “Effective Date”), by and between Jane Pritchett Henderson (“Executive”) and Apogee Therapeutics, Inc. (the “Company”). This Agreement amends and restates in its entirety the Executive Employment Agreement dated as of January 12, 2023.
